Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Alkaline Phosphatase | 43 | 2023 | 864 | 10.220 |
Why?
|
Intestinal Mucosa | 30 | 2023 | 3036 | 3.390 |
Why?
|
Adrenalectomy | 12 | 2022 | 339 | 1.960 |
Why?
|
Parathyroidectomy | 10 | 2021 | 234 | 1.700 |
Why?
|
Enterocytes | 10 | 2005 | 225 | 1.610 |
Why?
|
Intestines | 14 | 2021 | 1919 | 1.360 |
Why?
|
Intestine, Small | 11 | 2016 | 1242 | 1.240 |
Why?
|
Butyrates | 11 | 2006 | 165 | 1.150 |
Why?
|
Proctocolectomy, Restorative | 7 | 2021 | 189 | 1.100 |
Why?
|
Diverticulitis, Colonic | 4 | 2021 | 126 | 1.070 |
Why?
|
Hyperparathyroidism | 5 | 2017 | 339 | 1.050 |
Why?
|
Antigens, Neoplasm | 8 | 2008 | 1977 | 1.030 |
Why?
|
HT29 Cells | 12 | 2014 | 200 | 1.000 |
Why?
|
Triiodothyronine | 11 | 2003 | 491 | 0.980 |
Why?
|
Colitis, Ulcerative | 14 | 2021 | 1899 | 0.930 |
Why?
|
Laparoscopy | 13 | 2020 | 2091 | 0.900 |
Why?
|
Lipopolysaccharides | 10 | 2023 | 2208 | 0.870 |
Why?
|
Colonic Pouches | 8 | 2020 | 121 | 0.830 |
Why?
|
Parathyroid Neoplasms | 6 | 2016 | 244 | 0.810 |
Why?
|
Adrenal Gland Neoplasms | 5 | 2022 | 735 | 0.810 |
Why?
|
Frozen Sections | 2 | 2021 | 154 | 0.790 |
Why?
|
Receptors, Thyroid Hormone | 13 | 2005 | 202 | 0.780 |
Why?
|
Cyclins | 7 | 2002 | 601 | 0.760 |
Why?
|
Ileum | 4 | 2021 | 563 | 0.740 |
Why?
|
Skin Diseases, Bacterial | 1 | 2020 | 66 | 0.720 |
Why?
|
Technetium Tc 99m Sestamibi | 5 | 2010 | 177 | 0.720 |
Why?
|
Gene Expression Regulation, Enzymologic | 6 | 2005 | 1213 | 0.680 |
Why?
|
Permeability | 6 | 2021 | 739 | 0.680 |
Why?
|
Dietary Supplements | 3 | 2017 | 3279 | 0.670 |
Why?
|
Adrenal Gland Diseases | 4 | 2016 | 138 | 0.650 |
Why?
|
Salmonella typhimurium | 4 | 2014 | 354 | 0.640 |
Why?
|
Transcriptional Activation | 9 | 2006 | 1783 | 0.640 |
Why?
|
GPI-Linked Proteins | 9 | 2021 | 433 | 0.630 |
Why?
|
Gastrointestinal Agents | 3 | 2014 | 494 | 0.610 |
Why?
|
Toll-Like Receptor 4 | 1 | 2021 | 560 | 0.600 |
Why?
|
General Surgery | 4 | 2019 | 1630 | 0.590 |
Why?
|
Fatty Liver, Alcoholic | 1 | 2017 | 40 | 0.590 |
Why?
|
Aspartame | 1 | 2016 | 18 | 0.590 |
Why?
|
Feces | 8 | 2022 | 1389 | 0.590 |
Why?
|
Caco-2 Cells | 11 | 2015 | 387 | 0.570 |
Why?
|
Disease Models, Animal | 10 | 2021 | 18003 | 0.570 |
Why?
|
Inflammatory Bowel Diseases | 6 | 2023 | 2397 | 0.560 |
Why?
|
Mice, Inbred C57BL | 18 | 2020 | 21863 | 0.540 |
Why?
|
Thyroid Gland | 6 | 2013 | 1169 | 0.530 |
Why?
|
Microvilli | 10 | 2013 | 241 | 0.520 |
Why?
|
Salmonella Infections | 2 | 2014 | 174 | 0.520 |
Why?
|
Tissue Adhesions | 1 | 2016 | 235 | 0.520 |
Why?
|
Colectomy | 7 | 2018 | 681 | 0.510 |
Why?
|
Duodenum | 1 | 2018 | 481 | 0.510 |
Why?
|
Pheochromocytoma | 2 | 2014 | 337 | 0.500 |
Why?
|
Azithromycin | 1 | 2016 | 194 | 0.500 |
Why?
|
Bone Remodeling | 1 | 2018 | 575 | 0.490 |
Why?
|
Mice, Knockout | 12 | 2021 | 14558 | 0.490 |
Why?
|
Appendectomy | 4 | 2003 | 398 | 0.480 |
Why?
|
Adenoma | 7 | 2016 | 2167 | 0.470 |
Why?
|
Thyroid Neoplasms | 12 | 2013 | 2267 | 0.470 |
Why?
|
Cell Differentiation | 16 | 2023 | 11460 | 0.460 |
Why?
|
Luciferases | 6 | 2006 | 734 | 0.460 |
Why?
|
Crohn Disease | 6 | 2014 | 2299 | 0.460 |
Why?
|
Thyroidectomy | 11 | 2014 | 876 | 0.460 |
Why?
|
Response Elements | 2 | 2005 | 310 | 0.450 |
Why?
|
Uridine Diphosphate | 1 | 2013 | 31 | 0.450 |
Why?
|
Tight Junctions | 1 | 2015 | 310 | 0.450 |
Why?
|
Postoperative Complications | 21 | 2021 | 15194 | 0.450 |
Why?
|
Promoter Regions, Genetic | 8 | 2014 | 5863 | 0.440 |
Why?
|
Faculty | 1 | 2016 | 376 | 0.440 |
Why?
|
Ambulatory Surgical Procedures | 5 | 2022 | 450 | 0.440 |
Why?
|
Preoperative Care | 6 | 2018 | 2238 | 0.430 |
Why?
|
Animals | 66 | 2023 | 168368 | 0.430 |
Why?
|
Glucose Intolerance | 1 | 2016 | 575 | 0.430 |
Why?
|
Colitis | 3 | 2023 | 1146 | 0.420 |
Why?
|
Point-of-Care Systems | 1 | 2021 | 1175 | 0.420 |
Why?
|
Femur | 1 | 2018 | 1297 | 0.410 |
Why?
|
RNA, Messenger | 23 | 2018 | 13002 | 0.410 |
Why?
|
Histones | 5 | 2003 | 2591 | 0.410 |
Why?
|
Liver Cirrhosis | 2 | 2021 | 1838 | 0.400 |
Why?
|
Sigmoid Diseases | 2 | 2012 | 50 | 0.390 |
Why?
|
Peritoneal Lavage | 1 | 2011 | 35 | 0.390 |
Why?
|
Mice | 29 | 2023 | 81002 | 0.390 |
Why?
|
Anus Diseases | 2 | 2014 | 59 | 0.390 |
Why?
|
Colonic Neoplasms | 6 | 2014 | 2530 | 0.380 |
Why?
|
Appendicitis | 4 | 2003 | 639 | 0.380 |
Why?
|
Gene Expression Regulation | 14 | 2016 | 12049 | 0.380 |
Why?
|
beta-Galactosidase | 5 | 2001 | 572 | 0.370 |
Why?
|
Transcription, Genetic | 11 | 2005 | 7709 | 0.370 |
Why?
|
Butyric Acid | 6 | 2014 | 55 | 0.370 |
Why?
|
Cecum | 1 | 2011 | 237 | 0.370 |
Why?
|
Burns | 2 | 2020 | 1808 | 0.360 |
Why?
|
Length of Stay | 9 | 2018 | 6295 | 0.360 |
Why?
|
Proto-Oncogene Proteins B-raf | 9 | 2012 | 2015 | 0.360 |
Why?
|
Voice | 1 | 2013 | 260 | 0.360 |
Why?
|
Flagellin | 1 | 2010 | 125 | 0.350 |
Why?
|
Transfection | 12 | 2011 | 5884 | 0.350 |
Why?
|
Bacterial Physiological Phenomena | 1 | 2010 | 123 | 0.350 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2014 | 606 | 0.340 |
Why?
|
Carcinoma, Papillary | 3 | 2012 | 779 | 0.340 |
Why?
|
Anti-Bacterial Agents | 4 | 2019 | 7136 | 0.340 |
Why?
|
Blotting, Northern | 9 | 2005 | 1583 | 0.330 |
Why?
|
Oligodeoxyribonucleotides | 1 | 2010 | 708 | 0.330 |
Why?
|
Peritonitis | 1 | 2011 | 365 | 0.330 |
Why?
|
Neck Dissection | 1 | 2010 | 196 | 0.330 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 7 | 2005 | 364 | 0.330 |
Why?
|
Histone Deacetylase Inhibitors | 4 | 2014 | 788 | 0.320 |
Why?
|
Hepatic Stellate Cells | 2 | 2020 | 110 | 0.320 |
Why?
|
Cyclin B | 2 | 2005 | 108 | 0.320 |
Why?
|
Hyperparathyroidism, Primary | 3 | 2016 | 155 | 0.320 |
Why?
|
Humans | 134 | 2023 | 739398 | 0.310 |
Why?
|
Starvation | 3 | 2014 | 135 | 0.310 |
Why?
|
Professional Competence | 1 | 2011 | 448 | 0.310 |
Why?
|
Laryngoscopy | 1 | 2013 | 703 | 0.300 |
Why?
|
Genes, Reporter | 7 | 2006 | 1549 | 0.300 |
Why?
|
Splenectomy | 2 | 2001 | 392 | 0.300 |
Why?
|
Metagenome | 1 | 2010 | 417 | 0.300 |
Why?
|
Clostridium Infections | 1 | 2014 | 549 | 0.300 |
Why?
|
Tumor Necrosis Factor-alpha | 5 | 2019 | 4400 | 0.290 |
Why?
|
Enteral Nutrition | 2 | 2014 | 758 | 0.290 |
Why?
|
Interleukin-1beta | 2 | 2016 | 970 | 0.290 |
Why?
|
Abdomen | 2 | 2010 | 1104 | 0.290 |
Why?
|
Parathyroid Glands | 2 | 2021 | 509 | 0.290 |
Why?
|
Sepsis | 1 | 2020 | 2571 | 0.280 |
Why?
|
Luciferases, Renilla | 1 | 2006 | 22 | 0.280 |
Why?
|
Epidermal Growth Factor | 4 | 2001 | 706 | 0.280 |
Why?
|
Defecation | 2 | 2020 | 187 | 0.270 |
Why?
|
Luciferases, Firefly | 1 | 2006 | 46 | 0.270 |
Why?
|
Inflammation Mediators | 2 | 2013 | 1890 | 0.270 |
Why?
|
Acetylation | 6 | 2006 | 1085 | 0.270 |
Why?
|
Thyroid Diseases | 3 | 2019 | 378 | 0.260 |
Why?
|
Drainage | 2 | 2013 | 1139 | 0.260 |
Why?
|
Administration, Oral | 4 | 2014 | 3909 | 0.260 |
Why?
|
DNA, Bacterial | 1 | 2010 | 1467 | 0.260 |
Why?
|
Male | 74 | 2021 | 349022 | 0.250 |
Why?
|
Rectum | 4 | 2014 | 900 | 0.250 |
Why?
|
Streptomycin | 2 | 2014 | 70 | 0.250 |
Why?
|
Short Bowel Syndrome | 1 | 2008 | 341 | 0.250 |
Why?
|
Cushing Syndrome | 2 | 2016 | 249 | 0.240 |
Why?
|
Parathyroid Hormone | 6 | 2016 | 1799 | 0.240 |
Why?
|
Inflammation | 4 | 2022 | 10534 | 0.240 |
Why?
|
Homeostasis | 4 | 2023 | 3348 | 0.240 |
Why?
|
Thyroid Nodule | 4 | 2012 | 750 | 0.240 |
Why?
|
Fatty Acids, Volatile | 2 | 2017 | 101 | 0.240 |
Why?
|
Phenylalanine | 2 | 2016 | 365 | 0.240 |
Why?
|
Critical Illness | 2 | 2014 | 2656 | 0.230 |
Why?
|
DNA-Binding Proteins | 5 | 2005 | 9622 | 0.230 |
Why?
|
Robotics | 1 | 2011 | 890 | 0.230 |
Why?
|
Carcinoma, Neuroendocrine | 2 | 2011 | 324 | 0.230 |
Why?
|
Cell Division | 10 | 2010 | 4575 | 0.230 |
Why?
|
Surgery, Computer-Assisted | 1 | 2011 | 1008 | 0.220 |
Why?
|
Insulin Resistance | 1 | 2016 | 3858 | 0.220 |
Why?
|
Retrospective Studies | 38 | 2022 | 76631 | 0.220 |
Why?
|
Human Growth Hormone | 1 | 2008 | 683 | 0.220 |
Why?
|
Hypocalcemia | 2 | 2014 | 191 | 0.220 |
Why?
|
Perioperative Care | 2 | 2009 | 995 | 0.220 |
Why?
|
Nitric Oxide Synthase | 5 | 1999 | 916 | 0.220 |
Why?
|
Surgical Procedures, Operative | 3 | 2010 | 1867 | 0.210 |
Why?
|
Parathyroid Diseases | 2 | 2019 | 48 | 0.210 |
Why?
|
Female | 61 | 2022 | 378853 | 0.210 |
Why?
|
Anastomotic Leak | 2 | 2013 | 162 | 0.210 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 2 | 2005 | 862 | 0.210 |
Why?
|
Panax | 1 | 2001 | 29 | 0.210 |
Why?
|
Gallbladder | 1 | 2003 | 300 | 0.200 |
Why?
|
Enterovirus | 1 | 2022 | 64 | 0.200 |
Why?
|
Thyroid Hormones | 1 | 2004 | 387 | 0.200 |
Why?
|
Intestinal Neoplasms | 1 | 2004 | 319 | 0.200 |
Why?
|
Transcription Factors | 4 | 2019 | 12120 | 0.190 |
Why?
|
Ganglioneuroma | 1 | 2021 | 58 | 0.190 |
Why?
|
Carbon Tetrachloride | 1 | 2021 | 64 | 0.190 |
Why?
|
Kruppel-Like Transcription Factors | 3 | 2014 | 502 | 0.190 |
Why?
|
Aging | 1 | 2020 | 8613 | 0.190 |
Why?
|
Lipid A | 1 | 2020 | 65 | 0.190 |
Why?
|
Splenomegaly | 1 | 2001 | 190 | 0.190 |
Why?
|
Adenomatous Polyposis Coli | 1 | 2002 | 224 | 0.190 |
Why?
|
Adrenocortical Hyperfunction | 1 | 2020 | 14 | 0.190 |
Why?
|
Common Bile Duct | 1 | 2021 | 109 | 0.190 |
Why?
|
Cell Line | 13 | 2013 | 15987 | 0.190 |
Why?
|
Obesity | 4 | 2021 | 12643 | 0.190 |
Why?
|
Proto-Oncogenes | 6 | 1994 | 321 | 0.190 |
Why?
|
Rats | 25 | 2020 | 24270 | 0.190 |
Why?
|
Down-Regulation | 6 | 2015 | 2999 | 0.190 |
Why?
|
Four-Dimensional Computed Tomography | 2 | 2012 | 144 | 0.190 |
Why?
|
Surgical Instruments | 1 | 2003 | 395 | 0.180 |
Why?
|
Histone Deacetylases | 2 | 2002 | 729 | 0.180 |
Why?
|
Retirement | 1 | 2021 | 212 | 0.180 |
Why?
|
Pancreaticoduodenectomy | 1 | 2023 | 501 | 0.180 |
Why?
|
Academic Medical Centers | 3 | 2020 | 2749 | 0.180 |
Why?
|
Ligation | 1 | 2021 | 453 | 0.180 |
Why?
|
Gene Expression | 5 | 1999 | 7788 | 0.180 |
Why?
|
Fecal Incontinence | 3 | 2020 | 239 | 0.180 |
Why?
|
Adult | 43 | 2021 | 213394 | 0.180 |
Why?
|
Indoles | 4 | 2011 | 1832 | 0.180 |
Why?
|
Somatostatin | 2 | 2006 | 460 | 0.170 |
Why?
|
Chromatin | 2 | 2003 | 2848 | 0.170 |
Why?
|
Bacterial Translocation | 2 | 2010 | 73 | 0.170 |
Why?
|
Middle Aged | 43 | 2022 | 212863 | 0.170 |
Why?
|
Lactase | 5 | 2001 | 69 | 0.170 |
Why?
|
Intestinal Perforation | 1 | 2021 | 252 | 0.170 |
Why?
|
Weaning | 2 | 2016 | 105 | 0.170 |
Why?
|
Enterocolitis, Pseudomembranous | 1 | 2021 | 264 | 0.170 |
Why?
|
Anastomosis, Surgical | 4 | 2019 | 983 | 0.170 |
Why?
|
Proto-Oncogene Proteins | 9 | 1993 | 4555 | 0.160 |
Why?
|
Diverticulitis | 1 | 2021 | 169 | 0.160 |
Why?
|
Interleukin-8 | 2 | 2013 | 685 | 0.160 |
Why?
|
Anal Canal | 2 | 2019 | 373 | 0.160 |
Why?
|
Sulfonamides | 4 | 2011 | 1934 | 0.160 |
Why?
|
Cholecystectomy, Laparoscopic | 1 | 2000 | 224 | 0.160 |
Why?
|
Tumor Cells, Cultured | 6 | 2002 | 6310 | 0.160 |
Why?
|
Education, Medical, Graduate | 2 | 2010 | 2275 | 0.160 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 2018 | 226 | 0.160 |
Why?
|
Up-Regulation | 3 | 2020 | 4205 | 0.160 |
Why?
|
Viruses | 1 | 2022 | 375 | 0.160 |
Why?
|
Abscess | 3 | 2021 | 605 | 0.160 |
Why?
|
Blotting, Western | 4 | 2015 | 5181 | 0.160 |
Why?
|
Rats, Sprague-Dawley | 12 | 2002 | 8299 | 0.160 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2001 | 3615 | 0.160 |
Why?
|
Quorum Sensing | 1 | 2019 | 131 | 0.160 |
Why?
|
Liver | 7 | 2020 | 7449 | 0.160 |
Why?
|
Laparotomy | 2 | 2015 | 472 | 0.160 |
Why?
|
Authorship | 1 | 2021 | 268 | 0.150 |
Why?
|
Peer Review, Research | 1 | 2021 | 327 | 0.150 |
Why?
|
Radionuclide Imaging | 4 | 2007 | 2028 | 0.150 |
Why?
|
Cattle | 2 | 2016 | 3913 | 0.150 |
Why?
|
Computer Simulation | 1 | 2011 | 6237 | 0.150 |
Why?
|
Postoperative Care | 3 | 2018 | 1477 | 0.150 |
Why?
|
Triglycerides | 2 | 2017 | 2447 | 0.150 |
Why?
|
Radiopharmaceuticals | 1 | 2007 | 2687 | 0.140 |
Why?
|
Biotransformation | 1 | 2016 | 165 | 0.140 |
Why?
|
Acholeplasma | 1 | 2016 | 1 | 0.140 |
Why?
|
Carcinoma | 3 | 2010 | 2361 | 0.140 |
Why?
|
Interferon-gamma | 3 | 1999 | 3193 | 0.140 |
Why?
|
Societies, Medical | 2 | 2010 | 3739 | 0.140 |
Why?
|
Antibodies, Monoclonal | 3 | 2014 | 9259 | 0.140 |
Why?
|
Genetic Vectors | 2 | 2006 | 3419 | 0.140 |
Why?
|
Ascitic Fluid | 1 | 2016 | 192 | 0.140 |
Why?
|
X-Ray Microtomography | 1 | 2018 | 426 | 0.140 |
Why?
|
Aged | 33 | 2021 | 162698 | 0.140 |
Why?
|
Weight Gain | 2 | 2016 | 2278 | 0.140 |
Why?
|
Microfilament Proteins | 3 | 2004 | 1150 | 0.140 |
Why?
|
Enzyme Inhibitors | 5 | 2016 | 3802 | 0.140 |
Why?
|
Quality Assurance, Health Care | 1 | 2006 | 2213 | 0.130 |
Why?
|
Dehydroepiandrosterone Sulfate | 1 | 2016 | 238 | 0.130 |
Why?
|
Molecular Typing | 1 | 2016 | 108 | 0.130 |
Why?
|
Immunity, Mucosal | 1 | 2019 | 491 | 0.130 |
Why?
|
Pain, Postoperative | 2 | 2003 | 1638 | 0.130 |
Why?
|
Bacteroides | 1 | 2016 | 161 | 0.130 |
Why?
|
Gastric Bypass | 2 | 2015 | 809 | 0.130 |
Why?
|
Enteroendocrine Cells | 1 | 2016 | 54 | 0.130 |
Why?
|
Surgical Stapling | 1 | 1996 | 97 | 0.130 |
Why?
|
Homeodomain Proteins | 1 | 2005 | 2409 | 0.130 |
Why?
|
Lipogenesis | 1 | 2017 | 210 | 0.130 |
Why?
|
Carcinoma, Lewis Lung | 1 | 2015 | 115 | 0.130 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 1999 | 782 | 0.130 |
Why?
|
Escherichia coli | 3 | 2014 | 4220 | 0.130 |
Why?
|
Hyperthyroidism | 3 | 2010 | 293 | 0.130 |
Why?
|
Ostomy | 1 | 2014 | 26 | 0.130 |
Why?
|
Treatment Outcome | 17 | 2020 | 62693 | 0.130 |
Why?
|
Dextran Sulfate | 2 | 2016 | 236 | 0.130 |
Why?
|
Bombesin | 1 | 1994 | 33 | 0.130 |
Why?
|
Morganella morganii | 1 | 2014 | 3 | 0.130 |
Why?
|
Plasmids | 3 | 2005 | 2307 | 0.120 |
Why?
|
Malpractice | 1 | 2019 | 568 | 0.120 |
Why?
|
Deoxyribonucleotides | 1 | 2014 | 42 | 0.120 |
Why?
|
Alanine Transaminase | 1 | 2017 | 591 | 0.120 |
Why?
|
Cytomegalovirus Infections | 1 | 2021 | 808 | 0.120 |
Why?
|
Receptor, Parathyroid Hormone, Type 1 | 1 | 2015 | 305 | 0.120 |
Why?
|
Rectal Fistula | 1 | 2014 | 73 | 0.120 |
Why?
|
Ampicillin | 1 | 2014 | 138 | 0.120 |
Why?
|
Acetamides | 1 | 2016 | 248 | 0.120 |
Why?
|
Cachexia | 1 | 2015 | 203 | 0.120 |
Why?
|
Cells, Cultured | 4 | 2018 | 19220 | 0.120 |
Why?
|
Genes, Immediate-Early | 1 | 1994 | 101 | 0.120 |
Why?
|
Cell Cycle Proteins | 1 | 2005 | 3433 | 0.120 |
Why?
|
Electrophoretic Mobility Shift Assay | 2 | 2005 | 301 | 0.120 |
Why?
|
Azepines | 1 | 2016 | 335 | 0.120 |
Why?
|
Time Factors | 15 | 2019 | 40050 | 0.120 |
Why?
|
Absorption | 1 | 2013 | 248 | 0.110 |
Why?
|
Coculture Techniques | 1 | 2017 | 1343 | 0.110 |
Why?
|
Ischemia | 1 | 2002 | 1908 | 0.110 |
Why?
|
Carrier Proteins | 4 | 2001 | 5012 | 0.110 |
Why?
|
Pituitary Gland, Anterior | 2 | 1993 | 177 | 0.110 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2014 | 11410 | 0.110 |
Why?
|
Azo Compounds | 1 | 2013 | 114 | 0.110 |
Why?
|
Base Sequence | 7 | 2005 | 12804 | 0.110 |
Why?
|
Electric Impedance | 2 | 2015 | 720 | 0.110 |
Why?
|
Enterococcus faecalis | 1 | 2014 | 251 | 0.110 |
Why?
|
Otolaryngology | 1 | 2019 | 644 | 0.110 |
Why?
|
Jejunum | 1 | 2014 | 480 | 0.110 |
Why?
|
Mutation | 7 | 2014 | 29658 | 0.100 |
Why?
|
Follow-Up Studies | 11 | 2016 | 38942 | 0.100 |
Why?
|
Patient Selection | 4 | 2020 | 4211 | 0.100 |
Why?
|
Graves Disease | 1 | 2013 | 241 | 0.100 |
Why?
|
Binding Sites | 4 | 2014 | 6113 | 0.100 |
Why?
|
Quality of Life | 4 | 2019 | 12640 | 0.100 |
Why?
|
Receptors, Purinergic P2 | 1 | 2013 | 151 | 0.100 |
Why?
|
Multivariate Analysis | 6 | 2019 | 12237 | 0.100 |
Why?
|
Models, Animal | 1 | 2018 | 2164 | 0.100 |
Why?
|
Postoperative Period | 4 | 2023 | 1835 | 0.100 |
Why?
|
Chloramphenicol O-Acetyltransferase | 3 | 2001 | 222 | 0.100 |
Why?
|
COS Cells | 2 | 2003 | 1159 | 0.100 |
Why?
|
Pseudomonas aeruginosa | 1 | 2019 | 1208 | 0.100 |
Why?
|
Parenteral Nutrition, Total | 1 | 2012 | 300 | 0.100 |
Why?
|
Sodium-Potassium-Chloride Symporters | 3 | 2001 | 102 | 0.100 |
Why?
|
Fluorescent Antibody Technique | 1 | 2015 | 2503 | 0.100 |
Why?
|
Tachycardia | 1 | 2014 | 621 | 0.100 |
Why?
|
Gram-Negative Aerobic Bacteria | 1 | 2010 | 8 | 0.100 |
Why?
|
Gram-Negative Anaerobic Bacteria | 1 | 2010 | 16 | 0.100 |
Why?
|
NF-kappa B | 1 | 2000 | 2502 | 0.100 |
Why?
|
Diarrhea | 2 | 2014 | 1342 | 0.100 |
Why?
|
Drug Resistance, Bacterial | 2 | 2019 | 1031 | 0.100 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2010 | 8400 | 0.100 |
Why?
|
Apoptosis | 3 | 2002 | 9714 | 0.100 |
Why?
|
HCT116 Cells | 2 | 2014 | 409 | 0.100 |
Why?
|
Drosophila melanogaster | 1 | 2020 | 1703 | 0.090 |
Why?
|
Hypotension, Orthostatic | 1 | 2014 | 258 | 0.090 |
Why?
|
Hematoma | 2 | 2019 | 754 | 0.090 |
Why?
|
Endocrine Glands | 1 | 2010 | 102 | 0.090 |
Why?
|
Chi-Square Distribution | 3 | 2012 | 3510 | 0.090 |
Why?
|
Ethanol | 1 | 2017 | 1329 | 0.090 |
Why?
|
Tissue Plasminogen Activator | 1 | 2017 | 1263 | 0.090 |
Why?
|
Wiskott-Aldrich Syndrome | 1 | 2011 | 131 | 0.090 |
Why?
|
Gene Expression Profiling | 3 | 2014 | 9387 | 0.090 |
Why?
|
Wound Healing | 2 | 2019 | 2768 | 0.090 |
Why?
|
Decision Trees | 1 | 2012 | 507 | 0.090 |
Why?
|
Internship and Residency | 2 | 2010 | 5761 | 0.090 |
Why?
|
Calcitonin | 1 | 2011 | 336 | 0.090 |
Why?
|
Wiskott-Aldrich Syndrome Protein | 1 | 2011 | 160 | 0.090 |
Why?
|
Genetic Heterogeneity | 1 | 2014 | 727 | 0.090 |
Why?
|
Hepatocytes | 1 | 2017 | 1202 | 0.090 |
Why?
|
Seroma | 1 | 2010 | 69 | 0.090 |
Why?
|
Renal Insufficiency | 1 | 2015 | 803 | 0.090 |
Why?
|
Periodicals as Topic | 1 | 2021 | 1428 | 0.090 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 2010 | 769 | 0.090 |
Why?
|
Lymph Nodes | 3 | 2010 | 3454 | 0.090 |
Why?
|
Cytokines | 2 | 2017 | 7298 | 0.090 |
Why?
|
Lung Neoplasms | 4 | 2022 | 12985 | 0.080 |
Why?
|
Perception | 1 | 2015 | 1177 | 0.080 |
Why?
|
Adenosine Triphosphate | 2 | 2014 | 2022 | 0.080 |
Why?
|
Adenocarcinoma, Follicular | 1 | 2012 | 320 | 0.080 |
Why?
|
Food | 1 | 1994 | 760 | 0.080 |
Why?
|
Reoperation | 2 | 2015 | 4192 | 0.080 |
Why?
|
RNA, Bacterial | 1 | 2010 | 393 | 0.080 |
Why?
|
Thrombospondin 1 | 1 | 2010 | 250 | 0.080 |
Why?
|
Pancreatic Neoplasms | 1 | 2006 | 5213 | 0.080 |
Why?
|
DNA Primers | 1 | 2013 | 2893 | 0.080 |
Why?
|
Boston | 4 | 2006 | 9314 | 0.080 |
Why?
|
Molecular Sequence Data | 7 | 2005 | 18125 | 0.080 |
Why?
|
Listeria monocytogenes | 1 | 2010 | 249 | 0.080 |
Why?
|
Recombinant Proteins | 3 | 2003 | 6610 | 0.080 |
Why?
|
Patient Education as Topic | 1 | 2018 | 2275 | 0.080 |
Why?
|
Hydroxamic Acids | 2 | 2001 | 495 | 0.080 |
Why?
|
Models, Economic | 1 | 2012 | 723 | 0.080 |
Why?
|
Nitric Oxide | 4 | 2020 | 2121 | 0.080 |
Why?
|
Actins | 4 | 2004 | 2112 | 0.080 |
Why?
|
Peroxidase | 1 | 2011 | 608 | 0.080 |
Why?
|
Cell Membrane Permeability | 2 | 1999 | 589 | 0.080 |
Why?
|
Weight Loss | 2 | 2016 | 2589 | 0.080 |
Why?
|
Aged, 80 and over | 10 | 2012 | 57650 | 0.080 |
Why?
|
Hypoglycemia | 1 | 2014 | 855 | 0.070 |
Why?
|
Macrophages | 2 | 2020 | 5631 | 0.070 |
Why?
|
Phenotype | 4 | 2022 | 16301 | 0.070 |
Why?
|
Protein Synthesis Inhibitors | 2 | 1998 | 192 | 0.070 |
Why?
|
Phosphorylation | 3 | 2020 | 8416 | 0.070 |
Why?
|
Body Composition | 1 | 2016 | 2397 | 0.070 |
Why?
|
Ultrasonography | 4 | 2012 | 5941 | 0.070 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2010 | 946 | 0.070 |
Why?
|
Inpatients | 2 | 2021 | 2478 | 0.070 |
Why?
|
Vipoma | 1 | 2006 | 7 | 0.070 |
Why?
|
Somatostatinoma | 1 | 2006 | 10 | 0.070 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2010 | 2936 | 0.070 |
Why?
|
Adolescent | 14 | 2015 | 85405 | 0.070 |
Why?
|
Toll-Like Receptors | 1 | 2010 | 591 | 0.070 |
Why?
|
Interleukin-6 | 2 | 2020 | 3194 | 0.070 |
Why?
|
Cohort Studies | 9 | 2022 | 40389 | 0.070 |
Why?
|
Adenocarcinoma | 1 | 2004 | 6318 | 0.070 |
Why?
|
Atrophy | 3 | 2015 | 1571 | 0.070 |
Why?
|
Biopsy, Fine-Needle | 4 | 2012 | 1089 | 0.070 |
Why?
|
False Negative Reactions | 1 | 2007 | 589 | 0.070 |
Why?
|
Prognosis | 6 | 2015 | 28901 | 0.070 |
Why?
|
Cyclin B1 | 1 | 2005 | 51 | 0.070 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2010 | 1470 | 0.070 |
Why?
|
Analysis of Variance | 2 | 2014 | 6370 | 0.070 |
Why?
|
Colon | 1 | 2014 | 1771 | 0.070 |
Why?
|
Severity of Illness Index | 5 | 2020 | 15511 | 0.070 |
Why?
|
Endotoxins | 2 | 2019 | 524 | 0.070 |
Why?
|
Spleen | 2 | 2010 | 2359 | 0.070 |
Why?
|
Acetyltransferases | 1 | 2006 | 236 | 0.070 |
Why?
|
Cycloheximide | 3 | 1994 | 347 | 0.060 |
Why?
|
TATA Box | 1 | 2005 | 128 | 0.060 |
Why?
|
Fibroblasts | 1 | 2015 | 4137 | 0.060 |
Why?
|
Medical Audit | 1 | 2006 | 466 | 0.060 |
Why?
|
Young Adult | 12 | 2015 | 56255 | 0.060 |
Why?
|
Blood Glucose | 2 | 2016 | 6237 | 0.060 |
Why?
|
Receptors, Retinoic Acid | 1 | 2005 | 232 | 0.060 |
Why?
|
Histone Acetyltransferases | 1 | 2006 | 336 | 0.060 |
Why?
|
Thyroid Hormone Receptors alpha | 1 | 2004 | 14 | 0.060 |
Why?
|
Thyroid Hormone Receptors beta | 1 | 2004 | 21 | 0.060 |
Why?
|
Retinoid X Receptors | 1 | 2004 | 92 | 0.060 |
Why?
|
Half-Life | 1 | 2005 | 658 | 0.060 |
Why?
|
False Positive Reactions | 1 | 2007 | 982 | 0.060 |
Why?
|
Obesity, Morbid | 1 | 2015 | 1191 | 0.060 |
Why?
|
Bacteria | 2 | 2010 | 2106 | 0.060 |
Why?
|
User-Computer Interface | 1 | 2011 | 1423 | 0.060 |
Why?
|
Neoplasm Staging | 3 | 2019 | 10961 | 0.060 |
Why?
|
Secondary Prevention | 1 | 2011 | 1516 | 0.060 |
Why?
|
Fasting | 3 | 1995 | 1587 | 0.060 |
Why?
|
Glucagon | 1 | 2006 | 532 | 0.060 |
Why?
|
Child | 10 | 2014 | 77033 | 0.060 |
Why?
|
Bacterial Proteins | 2 | 2019 | 3866 | 0.060 |
Why?
|
5' Untranslated Regions | 1 | 2005 | 250 | 0.060 |
Why?
|
Fistula | 1 | 2005 | 218 | 0.060 |
Why?
|
Survival Rate | 4 | 2022 | 12761 | 0.060 |
Why?
|
Locus Control Region | 1 | 2003 | 20 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2014 | 4743 | 0.060 |
Why?
|
Anthozoa | 1 | 2003 | 63 | 0.060 |
Why?
|
Phylogeny | 1 | 2010 | 2789 | 0.060 |
Why?
|
Primary Prevention | 1 | 2011 | 1165 | 0.060 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 5154 | 0.060 |
Why?
|
Enzymes | 2 | 1995 | 267 | 0.060 |
Why?
|
Risk Management | 1 | 2006 | 571 | 0.050 |
Why?
|
Autoradiography | 1 | 2003 | 765 | 0.050 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2017 | 3323 | 0.050 |
Why?
|
Fellowships and Scholarships | 1 | 2010 | 1058 | 0.050 |
Why?
|
Hospitals, General | 1 | 2006 | 744 | 0.050 |
Why?
|
Propylthiouracil | 2 | 2013 | 69 | 0.050 |
Why?
|
Logistic Models | 5 | 2012 | 13402 | 0.050 |
Why?
|
Precipitin Tests | 1 | 2003 | 829 | 0.050 |
Why?
|
Epithelial Cells | 1 | 2014 | 3671 | 0.050 |
Why?
|
Genotype | 2 | 2014 | 12951 | 0.050 |
Why?
|
Congresses as Topic | 1 | 2006 | 760 | 0.050 |
Why?
|
Enzyme Induction | 2 | 1999 | 475 | 0.050 |
Why?
|
Bacterial Infections | 1 | 2010 | 1391 | 0.050 |
Why?
|
Nucleotides | 1 | 2004 | 461 | 0.050 |
Why?
|
Hospital Costs | 2 | 1999 | 982 | 0.050 |
Why?
|
Mice, SCID | 3 | 2011 | 2716 | 0.050 |
Why?
|
Rectal Neoplasms | 1 | 2010 | 1192 | 0.050 |
Why?
|
Mutation, Missense | 1 | 2010 | 2552 | 0.050 |
Why?
|
Genetic Variation | 2 | 1994 | 6539 | 0.050 |
Why?
|
Proportional Hazards Models | 2 | 2018 | 12328 | 0.050 |
Why?
|
Patient Satisfaction | 3 | 2012 | 3382 | 0.050 |
Why?
|
Cyclin D | 1 | 2001 | 70 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 2016 | 5830 | 0.050 |
Why?
|
Mutagenesis | 1 | 2005 | 1265 | 0.050 |
Why?
|
Endoscopy | 1 | 2011 | 1762 | 0.050 |
Why?
|
Flow Cytometry | 2 | 2002 | 5959 | 0.050 |
Why?
|
Hyperplasia | 2 | 1995 | 1181 | 0.050 |
Why?
|
Nitric Oxide Synthase Type II | 2 | 1999 | 534 | 0.050 |
Why?
|
Guanidines | 2 | 1999 | 191 | 0.050 |
Why?
|
Constriction, Pathologic | 1 | 2004 | 1096 | 0.050 |
Why?
|
Nitrous Acid | 1 | 1999 | 8 | 0.050 |
Why?
|
Goblet Cells | 1 | 2023 | 288 | 0.050 |
Why?
|
Gene Silencing | 1 | 2006 | 1537 | 0.050 |
Why?
|
Substrate Specificity | 1 | 2004 | 1798 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 3 | 2010 | 20055 | 0.040 |
Why?
|
Blood Platelets | 1 | 2010 | 2506 | 0.040 |
Why?
|
Lymphatic Metastasis | 3 | 2012 | 2897 | 0.040 |
Why?
|
Antineoplastic Agents | 3 | 2011 | 13635 | 0.040 |
Why?
|
DNA Footprinting | 1 | 1999 | 98 | 0.040 |
Why?
|
Ileostomy | 1 | 2020 | 119 | 0.040 |
Why?
|
Protein Isoforms | 1 | 2004 | 1725 | 0.040 |
Why?
|
Receptors, Steroid | 2 | 1990 | 155 | 0.040 |
Why?
|
Receptors, Interferon | 1 | 1999 | 114 | 0.040 |
Why?
|
United States | 7 | 2021 | 69573 | 0.040 |
Why?
|
Incidence | 5 | 2016 | 20913 | 0.040 |
Why?
|
Cell Count | 2 | 2010 | 1833 | 0.040 |
Why?
|
Immunoblotting | 1 | 2002 | 1683 | 0.040 |
Why?
|
Epigastric Arteries | 1 | 1999 | 91 | 0.040 |
Why?
|
Anti-Inflammatory Agents | 1 | 2008 | 1777 | 0.040 |
Why?
|
Sp1 Transcription Factor | 1 | 1999 | 144 | 0.040 |
Why?
|
Perioperative Period | 1 | 2020 | 255 | 0.040 |
Why?
|
Plant Extracts | 1 | 2001 | 464 | 0.040 |
Why?
|
Immunomodulation | 1 | 2022 | 540 | 0.040 |
Why?
|
Endoscopes | 1 | 1999 | 170 | 0.040 |
Why?
|
Bumetanide | 1 | 1998 | 95 | 0.040 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2020 | 392 | 0.040 |
Why?
|
Program Evaluation | 1 | 2006 | 2484 | 0.040 |
Why?
|
Cell Nucleus | 3 | 2004 | 2965 | 0.040 |
Why?
|
Protein Binding | 2 | 2014 | 9375 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 1998 | 286 | 0.040 |
Why?
|
Liver Neoplasms | 2 | 2006 | 4216 | 0.040 |
Why?
|
Disease-Free Survival | 2 | 2022 | 6871 | 0.040 |
Why?
|
Anticarcinogenic Agents | 1 | 1999 | 250 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2012 | 9122 | 0.040 |
Why?
|
Leukocyte L1 Antigen Complex | 1 | 2017 | 88 | 0.040 |
Why?
|
Age Factors | 4 | 2012 | 18349 | 0.040 |
Why?
|
Ligands | 1 | 2004 | 3311 | 0.040 |
Why?
|
Endotoxemia | 1 | 1998 | 206 | 0.040 |
Why?
|
Fucosyltransferases | 1 | 2017 | 119 | 0.040 |
Why?
|
Pelvis | 1 | 2021 | 718 | 0.040 |
Why?
|
Cloning, Molecular | 2 | 1995 | 4319 | 0.040 |
Why?
|
Cell Survival | 1 | 2006 | 5877 | 0.040 |
Why?
|
Isoenzymes | 1 | 2001 | 1720 | 0.030 |
Why?
|
Cytomegalovirus | 1 | 2021 | 719 | 0.030 |
Why?
|
Delivery of Health Care | 1 | 2014 | 5272 | 0.030 |
Why?
|
Genetic Markers | 1 | 2003 | 2630 | 0.030 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2011 | 3908 | 0.030 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2021 | 1771 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2003 | 14740 | 0.030 |
Why?
|
Spherocytosis, Hereditary | 1 | 1996 | 80 | 0.030 |
Why?
|
Editorial Policies | 1 | 2021 | 446 | 0.030 |
Why?
|
Immunity, Innate | 1 | 2008 | 2950 | 0.030 |
Why?
|
Genes, jun | 1 | 1995 | 71 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2022 | 1453 | 0.030 |
Why?
|
Antibodies | 1 | 2004 | 2450 | 0.030 |
Why?
|
Chronic Disease | 1 | 2011 | 9133 | 0.030 |
Why?
|
Gastrointestinal Tract | 1 | 2022 | 814 | 0.030 |
Why?
|
Calcium | 3 | 2015 | 5742 | 0.030 |
Why?
|
Interleukin-1 | 1 | 1999 | 1262 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 1998 | 576 | 0.030 |
Why?
|
Pituitary Diseases | 1 | 2016 | 141 | 0.030 |
Why?
|
Odds Ratio | 3 | 2014 | 9846 | 0.030 |
Why?
|
Chlorides | 1 | 1998 | 667 | 0.030 |
Why?
|
Genes, fos | 1 | 1995 | 183 | 0.030 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 1998 | 436 | 0.030 |
Why?
|
Liver Transplantation | 1 | 2006 | 2110 | 0.030 |
Why?
|
Critical Care | 1 | 2008 | 2624 | 0.030 |
Why?
|
Rectovaginal Fistula | 1 | 2014 | 11 | 0.030 |
Why?
|
Virulence | 1 | 2019 | 1321 | 0.030 |
Why?
|
Fractures, Spontaneous | 1 | 1997 | 230 | 0.030 |
Why?
|
RNA Splicing | 2 | 1990 | 904 | 0.030 |
Why?
|
Protein Kinase C | 1 | 1999 | 1223 | 0.030 |
Why?
|
Intraoperative Period | 1 | 2016 | 519 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2010 | 15036 | 0.030 |
Why?
|
Cell Line, Tumor | 4 | 2014 | 16646 | 0.030 |
Why?
|
ABO Blood-Group System | 1 | 2017 | 366 | 0.030 |
Why?
|
Surgicenters | 1 | 2014 | 46 | 0.030 |
Why?
|
Massachusetts | 2 | 2021 | 8669 | 0.030 |
Why?
|
Pseudomonas Infections | 1 | 2019 | 607 | 0.030 |
Why?
|
Organ Specificity | 2 | 1990 | 2004 | 0.030 |
Why?
|
Sequence Alignment | 1 | 1999 | 2256 | 0.030 |
Why?
|
Tissue Engineering | 1 | 2004 | 1869 | 0.030 |
Why?
|
Thymidine | 1 | 1994 | 317 | 0.030 |
Why?
|
Hyperparathyroidism, Secondary | 1 | 2015 | 126 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2005 | 10945 | 0.030 |
Why?
|
Parathyroid Hormone-Related Protein | 1 | 2015 | 331 | 0.030 |
Why?
|
Pulmonary Edema | 2 | 1987 | 415 | 0.030 |
Why?
|
Cyclic AMP | 1 | 1998 | 1470 | 0.030 |
Why?
|
Treatment Failure | 2 | 2014 | 2614 | 0.030 |
Why?
|
Methimazole | 1 | 2013 | 41 | 0.030 |
Why?
|
Oxygen Consumption | 3 | 1997 | 1871 | 0.030 |
Why?
|
Potassium | 1 | 1998 | 1337 | 0.030 |
Why?
|
Video Recording | 1 | 1999 | 936 | 0.030 |
Why?
|
Hypertension | 1 | 2014 | 8431 | 0.030 |
Why?
|
Hypoparathyroidism | 1 | 2014 | 120 | 0.030 |
Why?
|
Immunoglobulins | 1 | 2017 | 881 | 0.030 |
Why?
|
Cost-Benefit Analysis | 2 | 2012 | 5462 | 0.030 |
Why?
|
Antithyroid Agents | 1 | 2013 | 68 | 0.030 |
Why?
|
Rats, Inbred Strains | 3 | 1990 | 2198 | 0.030 |
Why?
|
Disease Progression | 1 | 2010 | 13237 | 0.030 |
Why?
|
RNA, Viral | 1 | 2022 | 2907 | 0.030 |
Why?
|
Medical Records | 1 | 1999 | 1413 | 0.030 |
Why?
|
Blood Proteins | 1 | 1998 | 1122 | 0.030 |
Why?
|
Models, Biological | 2 | 2010 | 9609 | 0.030 |
Why?
|
Iatrogenic Disease | 1 | 2016 | 544 | 0.030 |
Why?
|
Polymerase Chain Reaction | 1 | 2003 | 6174 | 0.030 |
Why?
|
Perineum | 1 | 2014 | 211 | 0.030 |
Why?
|
Subcutaneous Fat | 1 | 2016 | 392 | 0.030 |
Why?
|
Morbidity | 1 | 1999 | 1763 | 0.030 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2021 | 3453 | 0.030 |
Why?
|
Sucrase | 1 | 1992 | 54 | 0.030 |
Why?
|
Patient Readmission | 2 | 2020 | 3106 | 0.030 |
Why?
|
Qualitative Research | 1 | 2021 | 2656 | 0.030 |
Why?
|
Mucous Membrane | 1 | 2016 | 667 | 0.030 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2001 | 2015 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2020 | 2711 | 0.030 |
Why?
|
Specialties, Surgical | 1 | 2017 | 385 | 0.030 |
Why?
|
Sexuality | 1 | 2014 | 173 | 0.030 |
Why?
|
Acute Disease | 2 | 2003 | 7128 | 0.030 |
Why?
|
Saccharomyces cerevisiae | 1 | 2003 | 2748 | 0.030 |
Why?
|
Purpura, Thrombocytopenic, Idiopathic | 1 | 1996 | 231 | 0.030 |
Why?
|
Multiple Endocrine Neoplasia Type 2a | 1 | 2011 | 44 | 0.030 |
Why?
|
Genes, Tumor Suppressor | 1 | 1997 | 1096 | 0.030 |
Why?
|
Protein Precursors | 1 | 1996 | 1154 | 0.030 |
Why?
|
DNA, Complementary | 1 | 1995 | 2049 | 0.030 |
Why?
|
Biomedical Research | 1 | 2007 | 3301 | 0.030 |
Why?
|
Thermogenesis | 1 | 2015 | 428 | 0.030 |
Why?
|
Mice, Inbred BALB C | 1 | 2020 | 6397 | 0.030 |
Why?
|
Intra-Abdominal Fat | 1 | 2016 | 590 | 0.020 |
Why?
|
Carcinoma, Medullary | 1 | 2011 | 122 | 0.020 |
Why?
|
Calcium-Binding Proteins | 1 | 1996 | 1078 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2001 | 2948 | 0.020 |
Why?
|
Drug Synergism | 1 | 1995 | 1792 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 1998 | 3863 | 0.020 |
Why?
|
Nucleic Acid Hybridization | 2 | 1990 | 1372 | 0.020 |
Why?
|
Clinical Competence | 1 | 2006 | 4671 | 0.020 |
Why?
|
Oncogenes | 1 | 1997 | 1264 | 0.020 |
Why?
|
Ion Channels | 1 | 2015 | 1056 | 0.020 |
Why?
|
Vitamin D | 2 | 2015 | 3197 | 0.020 |
Why?
|
Ablation Techniques | 1 | 2013 | 249 | 0.020 |
Why?
|
Cell Nucleus Size | 1 | 2010 | 11 | 0.020 |
Why?
|
Cell Nucleus Shape | 1 | 2010 | 16 | 0.020 |
Why?
|
Carcinoembryonic Antigen | 1 | 2011 | 347 | 0.020 |
Why?
|
Hypothyroidism | 1 | 1995 | 659 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 1999 | 3770 | 0.020 |
Why?
|
Cell Growth Processes | 1 | 2011 | 399 | 0.020 |
Why?
|
Signal Transduction | 3 | 2015 | 23355 | 0.020 |
Why?
|
CpG Islands | 1 | 2014 | 1163 | 0.020 |
Why?
|
Pyridines | 2 | 2014 | 2810 | 0.020 |
Why?
|
Heart Failure | 1 | 2014 | 10793 | 0.020 |
Why?
|
omega-N-Methylarginine | 2 | 1999 | 111 | 0.020 |
Why?
|
Nephrectomy | 1 | 2015 | 1033 | 0.020 |
Why?
|
Iodine Radioisotopes | 1 | 2013 | 1031 | 0.020 |
Why?
|
Neoadjuvant Therapy | 2 | 2010 | 2688 | 0.020 |
Why?
|
Stem Cells | 1 | 2023 | 3566 | 0.020 |
Why?
|
Gastric Mucosa | 1 | 1992 | 596 | 0.020 |
Why?
|
Chemistry | 1 | 1989 | 352 | 0.020 |
Why?
|
Mitochondrial Proteins | 1 | 2015 | 989 | 0.020 |
Why?
|
Eating | 1 | 1996 | 1526 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2011 | 480 | 0.020 |
Why?
|
Cell Nucleolus | 1 | 2010 | 166 | 0.020 |
Why?
|
Chemical Phenomena | 1 | 1989 | 517 | 0.020 |
Why?
|
Coronary Artery Bypass | 1 | 1999 | 2272 | 0.020 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2011 | 240 | 0.020 |
Why?
|
Risk Factors | 5 | 2014 | 71974 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2011 | 489 | 0.020 |
Why?
|
RNA | 2 | 2004 | 2723 | 0.020 |
Why?
|
Valine | 1 | 2010 | 413 | 0.020 |
Why?
|
Recurrence | 1 | 2021 | 8307 | 0.020 |
Why?
|
Choriocarcinoma | 1 | 1989 | 123 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2014 | 2881 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2014 | 2974 | 0.020 |
Why?
|
Benzamides | 1 | 2014 | 1374 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 1996 | 1674 | 0.020 |
Why?
|
Cell Shape | 1 | 2010 | 375 | 0.020 |
Why?
|
Adaptation, Physiological | 1 | 1995 | 1310 | 0.020 |
Why?
|
Preoperative Period | 1 | 2010 | 546 | 0.020 |
Why?
|
Thyrotropin | 1 | 2012 | 849 | 0.020 |
Why?
|
Incidental Findings | 1 | 2013 | 690 | 0.020 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2016 | 1214 | 0.020 |
Why?
|
Emergency Service, Hospital | 1 | 2008 | 7626 | 0.020 |
Why?
|
Benzenesulfonates | 1 | 2009 | 169 | 0.020 |
Why?
|
Watchful Waiting | 1 | 2012 | 489 | 0.020 |
Why?
|
Sex Factors | 2 | 2012 | 10398 | 0.020 |
Why?
|
Biopsy, Needle | 2 | 2009 | 1637 | 0.020 |
Why?
|
Cell Size | 1 | 2010 | 641 | 0.020 |
Why?
|
Neoplasms, Experimental | 1 | 1993 | 1280 | 0.020 |
Why?
|
Isoquinolines | 1 | 2009 | 371 | 0.020 |
Why?
|
Random Allocation | 1 | 2011 | 2417 | 0.020 |
Why?
|
Genes, p53 | 1 | 2009 | 752 | 0.020 |
Why?
|
Body Weight | 2 | 2010 | 4660 | 0.020 |
Why?
|
Niacinamide | 1 | 2009 | 415 | 0.020 |
Why?
|
Carcinoma, Hepatocellular | 1 | 1999 | 2185 | 0.020 |
Why?
|
Child, Preschool | 3 | 2014 | 40802 | 0.020 |
Why?
|
Risk Assessment | 3 | 2014 | 23294 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2010 | 1793 | 0.020 |
Why?
|
Feasibility Studies | 1 | 1995 | 5058 | 0.020 |
Why?
|
ROC Curve | 1 | 2013 | 3526 | 0.020 |
Why?
|
Phenylurea Compounds | 1 | 2009 | 524 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2014 | 3922 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2009 | 2084 | 0.020 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2010 | 1129 | 0.020 |
Why?
|
Radiotherapy | 1 | 2012 | 1526 | 0.020 |
Why?
|
Gastrins | 1 | 2004 | 81 | 0.020 |
Why?
|
Glutamic Acid | 1 | 2010 | 1168 | 0.020 |
Why?
|
Amino Acid Sequence | 4 | 1989 | 13816 | 0.020 |
Why?
|
Neutrophils | 1 | 2017 | 3698 | 0.020 |
Why?
|
Seizures | 2 | 1987 | 2829 | 0.020 |
Why?
|
Lymph Node Excision | 1 | 2010 | 1242 | 0.020 |
Why?
|
Databases, Factual | 1 | 2019 | 7690 | 0.020 |
Why?
|
S100 Proteins | 1 | 2004 | 259 | 0.010 |
Why?
|
Gastrointestinal Transit | 1 | 2004 | 96 | 0.010 |
Why?
|
Tumor Burden | 1 | 2010 | 1904 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 2 | 1990 | 2455 | 0.010 |
Why?
|
Functional Laterality | 1 | 2010 | 2291 | 0.010 |
Why?
|
Adipose Tissue | 1 | 2015 | 3280 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2011 | 3603 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 2011 | 2200 | 0.010 |
Why?
|
Immunohistochemistry | 2 | 2009 | 11347 | 0.010 |
Why?
|
Prospective Studies | 2 | 2020 | 53037 | 0.010 |
Why?
|
Cell Cycle | 1 | 2011 | 2960 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2010 | 2373 | 0.010 |
Why?
|
Rats, Inbred Lew | 1 | 2004 | 1160 | 0.010 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2011 | 3562 | 0.010 |
Why?
|
Appendix | 1 | 2003 | 108 | 0.010 |
Why?
|
Reference Values | 1 | 1990 | 4983 | 0.010 |
Why?
|
Pandemics | 1 | 2022 | 8274 | 0.010 |
Why?
|
Vitamin B 12 | 1 | 2004 | 527 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2010 | 4182 | 0.010 |
Why?
|
Recovery of Function | 1 | 2012 | 2924 | 0.010 |
Why?
|
Linear Models | 1 | 2011 | 5948 | 0.010 |
Why?
|
RNA Interference | 1 | 2010 | 2899 | 0.010 |
Why?
|
Cost of Illness | 1 | 2010 | 1849 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2013 | 4143 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2015 | 4920 | 0.010 |
Why?
|
1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt | 1 | 1999 | 5 | 0.010 |
Why?
|
DNA Methylation | 1 | 2014 | 4269 | 0.010 |
Why?
|
Peroxynitrous Acid | 1 | 1999 | 40 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 2 | 1999 | 2558 | 0.010 |
Why?
|
Cyclic N-Oxides | 1 | 1999 | 78 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2014 | 5148 | 0.010 |
Why?
|
Neovascularization, Pathologic | 1 | 2010 | 2639 | 0.010 |
Why?
|
Registries | 1 | 2014 | 8039 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2016 | 10142 | 0.010 |
Why?
|
Indicators and Reagents | 1 | 1999 | 460 | 0.010 |
Why?
|
Health Care Costs | 1 | 2012 | 3226 | 0.010 |
Why?
|
Organoids | 1 | 2004 | 687 | 0.010 |
Why?
|
Cell Movement | 1 | 2011 | 5221 | 0.010 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1999 | 821 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2010 | 8605 | 0.010 |
Why?
|
Dimethyl Sulfoxide | 1 | 1999 | 246 | 0.010 |
Why?
|
Free Radical Scavengers | 1 | 1999 | 218 | 0.010 |
Why?
|
DNA | 2 | 1989 | 7275 | 0.010 |
Why?
|
Culture Media | 1 | 1999 | 902 | 0.010 |
Why?
|
Bicuculline | 2 | 1987 | 99 | 0.010 |
Why?
|
Nitrites | 1 | 1997 | 161 | 0.010 |
Why?
|
Contrast Media | 1 | 2010 | 5293 | 0.010 |
Why?
|
RNA, Neoplasm | 1 | 1999 | 761 | 0.010 |
Why?
|
Software | 1 | 2010 | 4423 | 0.010 |
Why?
|
Nitrates | 1 | 1997 | 265 | 0.010 |
Why?
|
Ascorbic Acid | 1 | 1999 | 649 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2013 | 21694 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2012 | 7274 | 0.010 |
Why?
|
Proteins | 1 | 1990 | 6082 | 0.010 |
Why?
|
Medicaid | 1 | 2008 | 2711 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2010 | 12948 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2001 | 20676 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2008 | 5305 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 1999 | 1374 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2010 | 5502 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2009 | 10455 | 0.010 |
Why?
|
Enzyme Activation | 1 | 1999 | 3701 | 0.010 |
Why?
|
Imidazoles | 1 | 1999 | 1207 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2010 | 15500 | 0.010 |
Why?
|
Nuclear Receptor Subfamily 1, Group D, Member 1 | 1 | 1990 | 32 | 0.010 |
Why?
|
Equipment Design | 1 | 1999 | 3583 | 0.010 |
Why?
|
Brain | 2 | 1987 | 26345 | 0.010 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1989 | 1088 | 0.010 |
Why?
|
Genetic Complementation Test | 1 | 1989 | 563 | 0.000 |
Why?
|
DNA Probes | 1 | 1989 | 561 | 0.000 |
Why?
|
Pentylenetetrazole | 1 | 1987 | 69 | 0.000 |
Why?
|
Diagnostic Errors | 1 | 1994 | 1253 | 0.000 |
Why?
|
Electron Transport Complex IV | 1 | 1987 | 189 | 0.000 |
Why?
|
Mitochondria | 1 | 1997 | 3522 | 0.000 |
Why?
|
Membrane Proteins | 1 | 1999 | 7862 | 0.000 |
Why?
|
Kinetics | 1 | 1990 | 6475 | 0.000 |
Why?
|
Dexamethasone | 1 | 1989 | 1948 | 0.000 |
Why?
|
Protein Biosynthesis | 1 | 1989 | 2131 | 0.000 |
Why?
|
Blood Pressure | 1 | 1997 | 8554 | 0.000 |
Why?
|
Hemodynamics | 1 | 1987 | 4197 | 0.000 |
Why?
|